|cochlear limited stock price||0.83||0.1||15||26|
About Cochlear Ltd Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.How does cochlear’s implied growth ratio compare to the industry?
ATTRACTIVE:Cochlear exhibits an implied growth ratio which is less than the industry average for health care equipment & services stocks listed on the ASX. COH calculation: 10% - ($4.96 / $211.34) = 7.7% Implied Growth explained Price / Book 4.1 8.2 Industry Avg COHWhat is the net worth of cochlear?
Cochlear FY21 Net A$326.5M Vs. Loss A$238.2M >COH.AU Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants.What should every investor in Cochlear Limited (COH) be aware of?
Every investor in Cochlear Limited ( ASX:COH ) should be aware of the most powerful shareholder groups. Generally...